These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 17711889)
41. Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction. Emmer BJ; Steup-Beekman GM; Steens SC; Huizinga TW; van Buchem MA; van der Grond J Arthritis Rheum; 2008 May; 58(5):1451-7. PubMed ID: 18438847 [TBL] [Abstract][Full Text] [Related]
42. [Neuropsychiatric lupus and lupus nephritis as a clinical manifestations of systemic lupus erythematosus]. Rasić S; Dzemidzić J; Srna A; Aganović K; Rebić D; Muslimović A Med Arh; 2005; 59(6):393-5. PubMed ID: 16268075 [TBL] [Abstract][Full Text] [Related]
47. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature. García-Moreno JM; Chacón J Mov Disord; 2002 Nov; 17(6):1329-35. PubMed ID: 12465077 [TBL] [Abstract][Full Text] [Related]
48. [Neuropsychic manifestations in systemic lupus erythematosus (author's transl)]. García Puig J; Gil Aguado A; Barbado J; García Seoane J; Vázquez JJ Med Clin (Barc); 1979 Feb; 72(4):133-8. PubMed ID: 431177 [TBL] [Abstract][Full Text] [Related]
50. Management of neuropsychiatric lupus. Hanly JG; Harrison MJ Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):799-821. PubMed ID: 16150404 [TBL] [Abstract][Full Text] [Related]
51. [Neuropsychiatric symptoms in systemic lupus erythematosus]. Keren M; Apter A; Mani A; Tyano S Harefuah; 1991 Apr; 120(8):446-50. PubMed ID: 1885100 [TBL] [Abstract][Full Text] [Related]
52. [Characteristic manifestations of neuropsychiatric systemic lupus erythematosus]. Liu Z; Chen L; Cui LY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):509-12. PubMed ID: 16178450 [TBL] [Abstract][Full Text] [Related]
53. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265 [TBL] [Abstract][Full Text] [Related]
54. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Sanna G; Piga M; Terryberry JW; Peltz MT; Giagheddu S; Satta L; Ahmed A; Cauli A; Montaldo C; Passiu G; Peter JB; Shoenfeld Y; Mathieu A Lupus; 2000; 9(8):573-83. PubMed ID: 11035431 [TBL] [Abstract][Full Text] [Related]
55. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. Sibley JT; Olszynski WP; Decoteau WE; Sundaram MB J Rheumatol; 1992 Jan; 19(1):47-52. PubMed ID: 1556699 [TBL] [Abstract][Full Text] [Related]
56. Measuring permanent damage in pediatric systemic lupus erythematosus. Hiraki LT; Hamilton J; Silverman ED Lupus; 2007; 16(8):657-62. PubMed ID: 17711904 [TBL] [Abstract][Full Text] [Related]
57. Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Kasitanon N; Louthrenoo W; Piyasirisilp S; Sukitawu W; Wichainun R Asian Pac J Allergy Immunol; 2002 Sep; 20(3):179-85. PubMed ID: 12587842 [TBL] [Abstract][Full Text] [Related]
60. Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. Bortoluzzi A; Scirè CA; Bombardieri S; Caniatti L; Conti F; De Vita S; Doria A; Ferraccioli G; Gremese E; Mansutti E; Mathieu A; Mosca M; Padovan M; Piga M; Tincani A; Tola MR; Tomietto P; Valesini G; Zen M; Govoni M; Rheumatology (Oxford); 2015 May; 54(5):891-8. PubMed ID: 25339643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]